Monopar Therapeutics Inc. (MNPR) Stock buybacks 2024–2025
Monopar Therapeutics Inc. (MNPR) annual stock buyback history — cash paid to repurchase common stock, per SEC filings.
$35.0MFY2025 · since FY2024: $0 → $35.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $35.0M | — |
| FY2024 | $0 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More MNPR financial trends
MNPR RevenueMNPR Net incomeMNPR Net marginMNPR Gross profitMNPR Gross marginMNPR Operating incomeMNPR Operating marginMNPR Operating cash flowMNPR Free cash flowMNPR Capital expendituresMNPR Return on equityMNPR Dividends paidMNPR Total assetsMNPR Total liabilitiesMNPR Shareholders’ equityMNPR overview →